Search for contacts, projects,
courses and publications

Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases

People

 

Molinari M.

(Responsible)

Abstract

In cellulo investigation of the mechanisms of action of non-competitive pharmacological chaperones that can recover misfolded mutant proteins and reduce the toxic accumulation of substrates therefore filling high unmet medical needs in the treatment of rare genetic and neurodegenerative disorders.

Additional information

Start date
01.01.2021
End date
01.01.2024
Duration
36 Months
Funding sources
Status
Active
Category
Innosuisse / Innovation projects